All Type of News
Health ministry to hold a hearing on new drug pricing system in coming October
In his September 16 reply on Health and Welfare Committee in the regular session of the National Assembly, Health and Welfare Minister Kim Sung-ho said the ministry is finding ways of improving the new drug-pricing ru...
30 percent of patients are excluded from insurance coverage of COX-2 inhibitor
One out of three patients treated with COX (cyclooxygenase)-2 inhibitor, an anti-arthritic agent, does not give access to the insurance coverage, a survey said recently.
The nationwide survey of 111 doctors in the ...
Viagra recorded top in drug adverse reaction report.
Viagra, an anti-impotence drug, has shown the top not only in number of its drug adverse reaction reports but also its sales in the market.
According to the KFDA's data for the inspection of the government administ...
Baekje Pharm opened Bundang branch office
Baekje Pharm said it established an additional branch office at Bundang and commenced the operation on September 16 as part of expanding the existing drug distribution network.
Thus, Baekje Pharm has a total of 13 ...
KGSP-accredited drug wholesalers top 1,088
Currently, 130 drug wholesalers are newly accredited as Korea Good Supply Practice (KGSP) system, since its mandatory enforcement from July 1 this year.
According to the tallies by the Korea Drug Wholesalers Associ...
Government to curtail tax deduction rate of R&D outlays
The government's proposal designed to shrink the tax incentives on pharmaceutical R&D sector seems likely to trigger a considerable resistance from the related circles.
The Ministry of Finance and Economy recently ...
73 clinical trials are underway for 53 new drugs
The Korea Food and Drug Administration (KFDA) said that 73 clinical trials are underway in Korea as of August 2002. These clinical trials are broken down by phase III (39 cases by 15 foreign-invested firms and 8 local...
MOHW agreed with KMA to withdraw GI drug non-reimbursement plan.
On Sept. 16 Rep. Kim Sung-soon of the National Assembly, Health and Welfare Committee revealed the agreement signed earlier between the MOHW and the KMA over the withdrawal of the GI drugs from the NHI non-reimburseme...
Zonisamide to label warning letters due to side effects.
The KFDA instructed all physicians and pharmacists on Sept. 16 carefully to monitor the hypohidrosis and rise of body temperatures for the patients, especially children who were medicated with Zonisamide, an anti-epil...
Locally produced antihemophilic B agents are safe, KGC says
In line with the recent report that some hemophiliacs in Korea are infected with AIDS during the administration of locally produced antihemophilic B agents, Korea Green Cross (KGC) has argued that this report is beyon...
